Dyne Therapeutics Inc

NASDAQ:DYN 4:00:00 PM EDT

25.44

+0.57 (+2.29%)

4:05:22 PM EDT: $25.44 0.00 (0.00%)

Market Cap (Intraday)	2.11B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.25 Million
Adjusted EPS	-$0.79

See more estimates

10-Day MA	$25.29
50-Day MA	$25.99
200-Day MA	$15.44

See more pivots

Dyne Therapeutics Inc Stock, NASDAQ:DYN

1560 Trapelo Road, Waltham, Massachusetts 02451

United States of America

Phone: +1.781.786.8230

Number of Employees: 141

http://www.dyne-tx.com

Description

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.